Depressive Disorder, Major: all 2,805 studies
Page 27 of 29. Open to participants first (565), then studies with results posted, then the rest; newest registration first within each.
- Hormonal Levels in Men With Major Depressive DisorderWithdrawnNCT00429689
- Prozac Treatment of Major Depression: Discontinuation StudyCompletedNCT00427128Phase 4
- Augmentation of the Antidepressant Action of Sertraline With Triiodothyronine (T3)and Reboxetine: Clinical Efficacy, Adverse Effects and Predictors of Response.CompletedNCT00421369Not applicable
- An Eight-week Study Evaluating the Efficacy of a 100mg Dose of Saredutant Once Daily, in Elderly Patients With Major Depressive DisorderCompletedNCT00415142Phase 3
- Evaluation of the Effects of Duloxetine on NorepinephrineCompletedNCT00414323Phase 1
- Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)CompletedNCT00413023Phase 2
- Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive DisorderCompletedNCT00411242Phase 3
- Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive DisorderCompletedNCT00411099Phase 3
- D-cycloserine for Major Depressive DisorderCompletedNCT00408031Phase 2
- Study for Evaluating Different Methods of Measuring Depression Treatment ResponseCompletedNCT00406952Not applicable
- A Double-blind Sham Controlled Trial of rTMS in Treatment Resistant Major DepressionCompletedNCT00402220Not applicable
- Lithium Versus Paroxetine in Patients With Major Depression Who Have a Family History of Bipolar Disorder or SuicideTerminatedNCT00400088Phase 3
- Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive DisorderCompletedNCT00385437Phase 2
- Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (SIRIUS)CompletedNCT00385307Phase 3
- Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed PatientsCompletedNCT00384436Phase 4
- Assessment of the Safety and Effectiveness of Cortical Stimulation in Subjects With Major Depressive DisorderTerminatedNCT00380042Phase 1
- A Study of the Cost Effectiveness of Generalist Care Managers for Depression Treatment in Medicaid RecipientsCompletedNCT00373477Not applicable
- Study on the Influence of Electroconvulsive Therapy (ECT) on Homocysteine LevelsCompletedNCT00370058Phase 4
- Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE4) in Depressed PatientsCompletedNCT00369798Phase 1
- A Local Register Study For Major Depression Of Paroxetine Controlled ReleaseCompletedNCT00368303Phase 3
- A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive DisorderCompletedNCT00368030Phase 3
- Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy SubjectsCompletedNCT00366652Phase 3
- An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive DisorderCompletedNCT00361491Phase 2
- Genetic Study of Liver Enzymes in Patients With Side Effects From AntidepressantsCompletedNCT00360256
- An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive DisorderCompletedNCT00358631Phase 2
- Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and AdolescentsCompletedNCT00353028Phase 4
- Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive DisorderCompletedNCT00351910Phase 3
- Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive DisorderCompletedNCT00351169Phase 3
- A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive DisorderCompletedNCT00345098Phase 3
- A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.Status unknownNCT00335205Phase 4
- Light Therapy for Elderly DepressionTerminatedNCT00332670Phase 2/3
- Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive DisordersCompletedNCT00326144Phase 3
- Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive DisordersCompletedNCT00326105Phase 3
- Interpersonal Psychotherapy for Severely Depressed InpatientsTerminatedNCT00325000Not applicable
- Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive DisorderCompletedNCT00321490Phase 3
- A Study of 6(S)-5-MTHF Among Serotonin Reuptake Inhibitor(SSRI)-Resistant Outpatients With Major Depressive Disorder (MDD)CompletedNCT00321152Phase 4
- Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive DisorderCompletedNCT00320268Phase 3
- Sexual Functioning Study With AntidepressantsCompletedNCT00316160Phase 4
- Creatine as a New Therapeutic Strategy in DepressionTerminatedNCT00313417Phase 4
- Treating Refractory Major Depressive Disorder With Repetitive Transcranial Magnetic StimulationCompletedNCT00305045Not applicable
- Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major DepressionCompletedNCT00300404Phase 3
- Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive DisorderCompletedNCT00300378Phase 3
- Memory Functioning and Antidepressant TreatmentCompletedNCT00296933Phase 3
- Deep Brain Stimulation for Refractory Major DepressionCompletedNCT00296920Phase 3
- Treatment of Depression Following Multiple Brain TestsCompletedNCT00296777Phase 4
- Are Two Antidepressants a Good Initial Treatment for Depression?CompletedNCT00296712Phase 4
- Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory DepressionTerminatedNCT00296686Phase 4
- Mineralocorticoid Receptor in the Treatment of Severe DepressionCompletedNCT00295347Not applicable
- The Effectiveness of Idazoxan in Treating TRDWithdrawnNCT00294944Phase 3
- Effect of Partial Sleep Deprivation on Cognition and Cytokines in Individuals With Major DepressionStatus unknownNCT00291239Phase 4
- Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive DisorderCompletedNCT00290914Phase 2
- EEG Biomarkers for Predicting Response to Antidepressant TherapyCompletedNCT00289523
- A Study of Omega-3 as an Augmentor of Antidepressant Treatment for Major DepressionStatus unknownNCT00289484Phase 2
- Pulsed Electro Magnetic Fields (PEMF) Treatment in Patients With Treatment-Resistant Major Depression in Ongoing Pharmacological Treatment of DepressionCompletedNCT00287703Phase 3
- Testosterone and Major DepressionCompletedNCT00286546
- Cellular Aging and Neurobiology of Depression StudyCompletedNCT00285935Not applicable
- Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major DepressionCompletedNCT00285766Phase 3
- Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major DepressionCompletedNCT00285727Not applicable
- Effectiveness Study of Vilazodone to Treat Depression and to Discover Genetic Markers Associated With ResponseCompletedNCT00285376Phase 3
- Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive DisorderCompletedNCT00278941Phase 3
- Study Evaluating Desvenlafaxine Sustained-Release (DVS-SR) in Adult Outpatients With Major Depressive DisorderCompletedNCT00277823Phase 3
- A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive Disorder (MDD)CompletedNCT00275197Phase 2
- Clinical Pharmacogenomics of Antidepressant ResponseStatus unknownNCT00269334Phase 4
- Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research GroupCompletedNCT00265291Phase 2
- Randomized, Placebo-controlled Trial of an AMPAkine in Major Depressive DisorderWithdrawnNCT00262665Phase 2
- Brain Abnormalities in Late-Onset Major DepressionCompletedNCT00260468
- Essential Fatty Acids for Major DepressionCompletedNCT00256412Not applicable
- Efficacy and Safety of SR58611A in Patients With Major Depressive DisorderCompletedNCT00252356Phase 3
- Efficacy and Safety of SR58611A in Patients With Major Depressive DisorderCompletedNCT00252330Phase 3
- Discontinuation Study Of Citalopram (Antidepressant) in Depressed AdolescentsWithdrawnNCT00249886Phase 3
- Effectiveness of Culturally Based Congruent Care in Treating Hispanics With Major Depressive DisorderCompletedNCT00247195Not applicable
- CONCERTA® (Methylphenidate Hydrochloride) as add-on Therapy in the Treatment of Adult Major Depressive Disorder.CompletedNCT00246233Phase 3
- Patient-Centered Depression Care for African AmericansStatus unknownNCT00243425Not applicable
- Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive DisorderCompletedNCT00242229Not applicable
- Escitalopram Combination Comparison Study for Adult Patients With Major Depressive DisorderStatus unknownNCT00239954Phase 3
- A Study of Omega-3 as a Treatment for Major DepressionStatus unknownNCT00238758Phase 2
- Wellbutrin XL, Major Depressive Disorder and Breast CancerCompletedNCT00234195Phase 4
- Investigation of a Combination Treatment of Escitalopram and rTMSCompletedNCT00232700Not applicable
- A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and of Quetiapine Fumarate (Seroquel®) as Potentiation SSRI's, and SNRI's Treatment in Major Depression With AnxietyCompletedNCT00229645Phase 4
- Study of Medication and Placebo Response in Major DepressionCompletedNCT00229476Phase 4
- Study of Genetic Differences in People With DepressionCompletedNCT00229463
- Estrogen and Perimenopausal DepressionCompletedNCT00229450Phase 4
- Medical and Psychiatric Co-Morbidity Among Treatment Resistant Patients With Major Depression DisorderCompletedNCT00229398
- Fibromyalgia in Men Suffering From PTSDCompletedNCT00229294
- Integrated Treatment for Cocaine and Mood Disorders - 1CompletedNCT00227812Phase 2
- Safety Study of ORG 34517 for Major Depression With Psychotic FeaturesCompletedNCT00226278Phase 2
- Impact of Caregiver Depression on Asthma in the ChildCompletedNCT00223288
- Pregnenolone Trial for Depression in Bipolar Disorders or Recurrent Major Depressive Disorder With Substance AbuseCompletedNCT00223197Phase 4
- Efficacy of 18-Months of Antidepressive Medication Plus CBT or Dynamic or Supportive Psychotherapy for Recurrent Major DepressionStatus unknownNCT00220623Phase 3
- A Naturalistic Study of the Efficacy and Safety of Escitalopram in Treatment Resistant DepressionStatus unknownNCT00220480Not applicable
- Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1CompletedNCT00218556Not applicable
- Effects of Duloxetine vs. Escitalopram on Heart Rate Variability in DepressionCompletedNCT00215228Phase 2/3
- Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive DisorderStatus unknownNCT00209807Phase 4
- Characterizing Psychological Consequences of Childhood TraumaCompletedNCT00209105
- Treatment of Reduced Heart Rate Variability Associated With Major Depression With Electroconvulsive TherapyCompletedNCT00209066
- Does Fluoxetine Have an Effect on the CNS CRF Systems in Women Abused in Childhood?CompletedNCT00208897Not applicable
- Thyroid Medication and Antidepressants for Treating Major DepressionCompletedNCT00208702Phase 4
- Abilify Therapy for Reducing Comorbid Substance AbuseCompletedNCT00208169Phase 4
- A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00208156Phase 3
- Risperidone vs. Paroxetine for Panic AttacksTerminatedNCT00206765Phase 2